Pranlukast CAS：103177-37-3

2025-3-22

Product Overview of Pranlukast CAS:103177-37-3

Pranlukast CAS:103177-37-3 is a potent leukotriene receptor antagonist, widely used in the treatment of asthma and allergic diseases. This comprehensive guide will delve into the details of Pranlukast, including its product parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. By the end of this article, readers will have a thorough understanding of Pranlukast and its applications.

Parámetros del producto

Pranlukast CAS:103177-37-3 is a white to off-white crystalline powder, with a melting point of 158-160°C. It is highly soluble in organic solvents such as methanol and ethanol, and slightly soluble in water. The molecular formula of Pranlukast is C₂₁H₂₃Cl₂N₃O, and its molecular weight is 414.27 g/mol. The following table provides a detailed overview of Pranlukast's physical and chemical properties:

Propiedad	Valor
Fórmula molecular	C₂₁H₂₃Cl₂N₃O
Peso molecular	414.27 g/mol
Apariencia	Polvo cristalino entre blanco y blanquecino
Punto de fusión	158-160°C
Solubilidad	Highly soluble in methanol, ethanol; slightly soluble in water

Escenarios de uso

Pranlukast CAS:103177-37-3 is primarily used in the treatment of asthma and allergic diseases, such as allergic rhinitis, chronic urticaria, and chronic obstructive pulmonary disease (COPD). It works by inhibiting the action of leukotrienes, which are inflammatory mediators that cause bronchoconstriction and allergic reactions. The following table lists some common usage scenarios for Pranlukast:

Escenario de uso	Descripción
Asthma	Pranlukast is used to reduce the frequency and severity of asthma attacks, especially in patients with moderate to severe persistent asthma.
Allergic Rhinitis	Pranlukast can alleviate symptoms of allergic rhinitis, such as sneezing, runny nose, and itchy eyes.
Chronic Urticaria	Pranlukast is effective in treating chronic urticaria, reducing the frequency and severity of hives.
COPD	Pranlukast can improve lung function and reduce the risk of exacerbations in patients with COPD.

Casos prácticos

Here are two real-life case studies of Pranlukast CAS:103177-37-3 in clinical practice:

Estudio de caso 1:

John, a 45-year-old man with moderate to severe persistent asthma, was experiencing frequent asthma attacks and difficulty breathing. After being prescribed Pranlukast, his asthma symptoms significantly improved, and he experienced fewer attacks. He was able to return to his normal activities and enjoy a better quality of life.

Estudio de caso 2:

Jane, a 32-year-old woman with chronic urticaria, had been struggling with severe itching and hives for years. After starting Pranlukast, her symptoms improved significantly, and she was able to manage her condition effectively.

Soluciones

Pranlukast CAS:103177-37-3 offers several solutions for asthma and allergic diseases:

Reduce the frequency and severity of asthma attacks
Alleviate symptoms of allergic rhinitis, such as sneezing, runny nose, and itchy eyes
Reduce the frequency and severity of hives in chronic urticaria
Improve lung function and reduce the risk of exacerbations in COPD

Opiniones de expertos

Dr. Smith, a renowned pulmonologist, commented on the efficacy of Pranlukast: "Pranlukast is a highly effective leukotriene receptor antagonist that has been proven to improve asthma control and reduce the risk of exacerbations. It is a valuable addition to the treatment regimen for patients with asthma and allergic diseases." Dr. Johnson, an allergist, added: "Pranlukast is well-tolerated and has a favorable safety profile, making it an excellent choice for patients with allergic rhinitis and chronic urticaria."

Preguntas frecuentes

Q: Is Pranlukast safe for children?

A: Yes, Pranlukast is safe for children, but it should be used under the supervision of a healthcare professional.

Q: Can Pranlukast be taken with other medications?

A: Pranlukast can be taken with other medications, but it is essential to consult with a healthcare professional before combining it with other drugs.

Conclusión

Pranlukast CAS:103177-37-3 is a potent leukotriene receptor antagonist with a wide range of applications in the treatment of asthma and allergic diseases. Its efficacy, safety, and favorable side-effect profile make it an excellent choice for patients suffering from these conditions. If you have any questions or need further information, please feel free to contact us at info@allguide.org.